COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abbott Laboratories | Common | 002824100 | 36,536 | 457,048 | SH | | SOLE | | 457,048 | 0 | 0 |
AbbVie Inc. | Common | 00287Y109 | 25,806 | 320,213 | SH | | SOLE | | 320,213 | 0 | 0 |
ABIOMED, Inc. | Common | 003654100 | 6,850 | 23,986 | SH | | SOLE | | 23,986 | 0 | 0 |
AC Immune SA | Shares | H00263105 | 868 | 171,813 | SH | | SOLE | | 171,813 | 0 | 0 |
Acadia Healthcare Company, Inc. | Common | 00404A109 | 5,075 | 173,155 | SH | | SOLE | | 173,155 | 0 | 0 |
ACADIA Pharmaceuticals Inc. | Common | 004225108 | 2,812 | 104,714 | SH | | SOLE | | 104,714 | 0 | 0 |
Acceleron Pharma Inc. | Common | 00434H108 | 8,773 | 188,388 | SH | | SOLE | | 188,388 | 0 | 0 |
Adaptimmune Therapeutics plc | Sponsored ADR | 00653A107 | 983 | 228,496 | SH | | SOLE | | 228,496 | 0 | 0 |
Aerie Pharmaceuticals, Inc. | Common | 00771V108 | 3,254 | 68,496 | SH | | SOLE | | 68,496 | 0 | 0 |
Aerpio Pharmaceuticals, Inc. | Common | 00810B105 | 667 | 740,000 | SH | | SOLE | | 740,000 | 0 | 0 |
Affimed N.V. | Common | N01045108 | 1,067 | 254,000 | SH | | SOLE | | 254,000 | 0 | 0 |
Agios Pharmaceuticals, Inc. | Common | 00847X104 | 6,189 | 91,776 | SH | | SOLE | | 91,776 | 0 | 0 |
Akebia Therapeutics, Inc. | Common | 00972D105 | 1,752 | 213,942 | SH | | SOLE | | 213,942 | 0 | 0 |
Albireo Pharma, Inc. | Common | 01345P106 | 4,026 | 125,000 | SH | | SOLE | | 125,000 | 0 | 0 |
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 50,788 | 375,705 | SH | | SOLE | | 375,705 | 0 | 0 |
Align Technology, Inc. | Common | 016255101 | 8,040 | 28,278 | SH | | SOLE | | 28,278 | 0 | 0 |
Alkermes plc | Shares | G01767105 | 7,227 | 198,048 | SH | | SOLE | | 198,048 | 0 | 0 |
Allakos Inc. | Common | 01671P100 | 989 | 24,414 | SH | | SOLE | | 24,414 | 0 | 0 |
Allergan plc | Shares | G0177J108 | 28,296 | 193,263 | SH | | SOLE | | 193,263 | 0 | 0 |
Alliqua BioMedical, Inc. | Common | 019621309 | 437 | 148,500 | SH | | SOLE | | 148,500 | 0 | 0 |
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 12,472 | 133,458 | SH | | SOLE | | 133,458 | 0 | 0 |
Amarin Corporation plc | Sponsored ADR | 023111206 | 12,692 | 611,352 | SH | | SOLE | | 611,352 | 0 | 0 |
AmerisourceBergen Corporation | Common | 03073E105 | 6,300 | 79,226 | SH | | SOLE | | 79,226 | 0 | 0 |
Amgen Inc. | Common | 031162100 | 133,819 | 704,383 | SH | | SOLE | | 704,383 | 0 | 0 |
Amicus Therapeutics, Inc. | Common | 03152W109 | 4,279 | 314,597 | SH | | SOLE | | 314,597 | 0 | 0 |
AnaptysBio, Inc. | Common | 032724106 | 4,810 | 65,845 | SH | | SOLE | | 65,845 | 0 | 0 |
Anthem, Inc. | Common | 036752103 | 40,567 | 141,358 | SH | | SOLE | | 141,358 | 0 | 0 |
ARCA biopharma, Inc. | Common | 00211Y407 | 303 | 811,227 | SH | | SOLE | | 811,227 | 0 | 0 |
Ardelyx, Inc. | Common | 039697107 | 1,790 | 639,370 | SH | | SOLE | | 639,370 | 0 | 0 |
Arena Pharmaceuticals, Inc. | Common | 040047607 | 2,343 | 52,262 | SH | | SOLE | | 52,262 | 0 | 0 |
argenx SE | Sponsored ADR | 04016X101 | 3,543 | 28,381 | SH | | SOLE | | 28,381 | 0 | 0 |
ArQule, Inc. | Common | 04269E107 | 1,198 | 250,000 | SH | | SOLE | | 250,000 | 0 | 0 |
Array BioPharma Inc. | Common | 04269X105 | 8,878 | 364,166 | SH | | SOLE | | 364,166 | 0 | 0 |
Arrowhead Pharmaceuticals, Inc. | Common | 04280A100 | 563 | 30,700 | SH | | SOLE | | 30,700 | 0 | 0 |
Ascendis Pharma A/S | Sponsored ADR | 04351P101 | 7,222 | 61,360 | SH | | SOLE | | 61,360 | 0 | 0 |
AstraZeneca PLC | Sponsored ADR | 046353108 | 14,595 | 360,998 | SH | | SOLE | | 360,998 | 0 | 0 |
Athenex, Inc. | Common | 04685N103 | 558 | 45,530 | SH | | SOLE | | 45,530 | 0 | 0 |
Audentes Therapeutics, Inc. | Common | 05070R104 | 2,051 | 52,574 | SH | | SOLE | | 52,574 | 0 | 0 |
Avadel Pharmaceuticals plc | Sponsored ADR | 05337M104 | 1,173 | 814,588 | SH | | SOLE | | 814,588 | 0 | 0 |
Bausch Health Companies Inc. | Common | 071734107 | 4,170 | 168,812 | SH | | SOLE | | 168,812 | 0 | 0 |
Baxter International Inc. | Common | 071813109 | 11,194 | 137,668 | SH | | SOLE | | 137,668 | 0 | 0 |
Becton, Dickinson and Company | Common | 075887109 | 15,414 | 61,721 | SH | | SOLE | | 61,721 | 0 | 0 |
BeiGene, Ltd. | Sponsored ADR | 07725L102 | 12,525 | 94,889 | SH | | SOLE | | 94,889 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | Common | 079481107 | 202 | 60,000 | SH | | SOLE | | 60,000 | 0 | 0 |
Bio-Techne Corporation | Common | 09073M104 | 4,309 | 21,701 | SH | | SOLE | | 21,701 | 0 | 0 |
Biogen Inc. | Common | 09062X103 | 74,289 | 314,278 | SH | | SOLE | | 314,278 | 0 | 0 |
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 19,728 | 222,086 | SH | | SOLE | | 222,086 | 0 | 0 |
bluebird bio, Inc. | Common | 09609G100 | 14,322 | 91,029 | SH | | SOLE | | 91,029 | 0 | 0 |
Blueprint Medicines Corporation | Common | 09627Y109 | 9,263 | 115,720 | SH | | SOLE | | 115,720 | 0 | 0 |
Boston Scientific Corporation | Common | 101137107 | 18,177 | 473,619 | SH | | SOLE | | 473,619 | 0 | 0 |
Bristol-Myers Squibb Company | Common | 110122108 | 35,212 | 738,044 | SH | | SOLE | | 738,044 | 0 | 0 |
Cardinal Health, Inc. | Common | 14149Y108 | 303 | 6,300 | SH | | SOLE | | 6,300 | 0 | 0 |
Celgene Corporation | Common | 151020104 | 139,030 | 1,473,710 | SH | | SOLE | | 1,473,710 | 0 | 0 |
Celldex Therapeutics, Inc. | Common | 15117B202 | 35 | 7,053 | SH | | SOLE | | 7,053 | 0 | 0 |
Cellectis SA | Sponsored ADR | 15117K103 | 3,173 | 173,035 | SH | | SOLE | | 173,035 | 0 | 0 |
Centene Corporation | Common | 15135B101 | 6,812 | 128,295 | SH | | SOLE | | 128,295 | 0 | 0 |
Charles River Laboratories International, Inc. | Common | 159864107 | 1,545 | 10,640 | SH | | SOLE | | 10,640 | 0 | 0 |
Cidara Therapeutics, Inc. | Common | 171757107 | 421 | 158,784 | SH | | SOLE | | 158,784 | 0 | 0 |
Cigna Corporation | Common | 125523100 | 18,777 | 116,756 | SH | | SOLE | | 116,756 | 0 | 0 |
Clearside Biomedical, Inc. | Common | 185063104 | 228 | 165,330 | SH | | SOLE | | 165,330 | 0 | 0 |
Clovis Oncology, Inc. | Common | 189464100 | 1,871 | 75,400 | SH | | SOLE | | 75,400 | 0 | 0 |
Coherus Biosciences, Inc. | Common | 19249H103 | 4,299 | 315,162 | SH | | SOLE | | 315,162 | 0 | 0 |
Community Health Systems, Inc. | Common | 203668108 | 761 | 203,935 | SH | | SOLE | | 203,935 | 0 | 0 |
Concert Pharmaceuticals, Inc. | Common | 206022105 | 548 | 45,362 | SH | | SOLE | | 45,362 | 0 | 0 |
CRISPR Therapeutics AG | Namen AKT | H17182108 | 6,371 | 178,348 | SH | | SOLE | | 178,348 | 0 | 0 |
CVS Health Corporation | Common | 126650100 | 27,308 | 506,364 | SH | | SOLE | | 506,364 | 0 | 0 |
Danaher Corporation | Common | 235851102 | 20,982 | 158,931 | SH | | SOLE | | 158,931 | 0 | 0 |
Denali Therapeutics Inc. | Common | 24823R105 | 450 | 19,372 | SH | | SOLE | | 19,372 | 0 | 0 |
DENTSPLY SIRONA Inc. | Common | 24906P109 | 7,762 | 156,521 | SH | | SOLE | | 156,521 | 0 | 0 |
Diplomat Pharmacy, Inc. | Common | 25456K101 | 1,248 | 214,845 | SH | | SOLE | | 214,845 | 0 | 0 |
Dr. Reddy's Laboratories Ltd. | Sponsored ADR | 256135203 | 1,172 | 28,950 | SH | | SOLE | | 28,950 | 0 | 0 |
Editas Medicine, Inc. | Common | 28106W103 | 1,875 | 76,668 | SH | | SOLE | | 76,668 | 0 | 0 |
Edwards Lifesciences Corporation | Common | 28176E108 | 10,867 | 56,798 | SH | | SOLE | | 56,798 | 0 | 0 |
Eli Lilly and Company | Common | 532457108 | 38,321 | 295,320 | SH | | SOLE | | 295,320 | 0 | 0 |
Endo International plc | Shares | G30401106 | 4,269 | 531,570 | SH | | SOLE | | 531,570 | 0 | 0 |
Epizyme, Inc. | Common | 29428V104 | 3,586 | 289,404 | SH | | SOLE | | 289,404 | 0 | 0 |
Esperion Therapeutics, Inc. | Common | 29664W105 | 7,412 | 184,607 | SH | | SOLE | | 184,607 | 0 | 0 |
Evolent Health, Inc. | Common | 30050B101 | 530 | 42,150 | SH | | SOLE | | 42,150 | 0 | 0 |
Exelixis, Inc. | Common | 30161Q104 | 16,148 | 678,467 | SH | | SOLE | | 678,467 | 0 | 0 |
FibroGen, Inc. | Common | 31572Q808 | 9,552 | 175,742 | SH | | SOLE | | 175,742 | 0 | 0 |
Foamix Pharmaceuticals Ltd | Shares | M46135105 | 1,128 | 300,781 | SH | | SOLE | | 300,781 | 0 | 0 |
Galapagos NV | Sponsored ADR | 36315X101 | 5,715 | 48,525 | SH | | SOLE | | 48,525 | 0 | 0 |
Genomic Health, Inc. | Common | 37244C101 | 1,858 | 26,531 | SH | | SOLE | | 26,531 | 0 | 0 |
Gilead Sciences, Inc. | Common | 375558103 | 113,728 | 1,749,388 | SH | | SOLE | | 1,749,388 | 0 | 0 |
GlaxoSmithKline plc | Shares | 37733W105 | 9,139 | 218,700 | SH | | SOLE | | 218,700 | 0 | 0 |
Global Blood Therapeutics, Inc. | Common | 37890U108 | 4,551 | 85,988 | SH | | SOLE | | 85,988 | 0 | 0 |
Global Medical REIT Inc. | Common | 37954A204 | 721 | 73,400 | SH | | SOLE | | 73,400 | 0 | 0 |
GW Pharmaceuticals plc | ADS | 36197T103 | 5,882 | 34,891 | SH | | SOLE | | 34,891 | 0 | 0 |
HCA Healthcare, Inc. | Common | 40412C101 | 11,678 | 89,569 | SH | | SOLE | | 89,569 | 0 | 0 |
HCP, Inc. | Common | 40414L109 | 1,424 | 45,500 | SH | | SOLE | | 45,500 | 0 | 0 |
Healthcare Realty Trust Incorporated | Common | 421946104 | 2,183 | 68,000 | SH | | SOLE | | 68,000 | 0 | 0 |
Healthcare Trust of America, Inc. | Common | 42225P501 | 1,315 | 46,000 | SH | | SOLE | | 46,000 | 0 | 0 |
Hologic, Inc. | Common | 436440101 | 946 | 19,546 | SH | | SOLE | | 19,546 | 0 | 0 |
Horizon Pharma plc | Shares | G4617B105 | 511 | 19,350 | SH | | SOLE | | 19,350 | 0 | 0 |
Humana Inc. | Common | 444859102 | 9,491 | 35,682 | SH | | SOLE | | 35,682 | 0 | 0 |
IDEXX Laboratories, Inc. | Common | 45168D104 | 14,233 | 63,654 | SH | | SOLE | | 63,654 | 0 | 0 |
Illumina, Inc. | Common | 452327109 | 73,793 | 237,514 | SH | | SOLE | | 237,514 | 0 | 0 |
ImmunoGen, Inc. | Common | 45253H101 | 456 | 168,190 | SH | | SOLE | | 168,190 | 0 | 0 |
Immunomedics, Inc. | Common | 452907108 | 5,526 | 287,687 | SH | | SOLE | | 287,687 | 0 | 0 |
Incyte Corporation | Common | 45337C102 | 45,511 | 529,133 | SH | | SOLE | | 529,133 | 0 | 0 |
Inogen, Inc. | Common | 45780L104 | 763 | 8,000 | SH | | SOLE | | 8,000 | 0 | 0 |
Intellia Therapeutics, Inc. | Common | 45826J105 | 2,567 | 150,290 | SH | | SOLE | | 150,290 | 0 | 0 |
Intercept Pharmaceuticals, Inc. | Common | 45845P108 | 6,631 | 59,275 | SH | | SOLE | | 59,275 | 0 | 0 |
Intra-Cellular Therapies, Inc. | Common | 46116X101 | 1,342 | 110,193 | SH | | SOLE | | 110,193 | 0 | 0 |
Intuitive Surgical, Inc. | Common | 46120E602 | 22,984 | 40,281 | SH | | SOLE | | 40,281 | 0 | 0 |
Ionis Pharmaceuticals, Inc. | Common | 462222100 | 8,906 | 109,720 | SH | | SOLE | | 109,720 | 0 | 0 |
Iovance Biotherapeutics, Inc. | Common | 462260100 | 2,063 | 216,908 | SH | | SOLE | | 216,908 | 0 | 0 |
IQVIA Holdings Inc. | Common | 46266C105 | 2,358 | 16,391 | SH | | SOLE | | 16,391 | 0 | 0 |
Jazz Pharmaceuticals plc | Shares | G50871105 | 9,645 | 67,471 | SH | | SOLE | | 67,471 | 0 | 0 |
Johnson & Johnson | Common | 478160104 | 125,530 | 897,990 | SH | | SOLE | | 897,990 | 0 | 0 |
Jounce Therapeutics, Inc. | Common | 481116101 | 63 | 10,127 | SH | | SOLE | | 10,127 | 0 | 0 |
Koninklijke Philips N.V. | NY Reg Sh | 500472303 | 3,489 | 85,400 | SH | | SOLE | | 85,400 | 0 | 0 |
Laboratory Corporation of America Holdings | Sponsored ADR | 50540R409 | 6,985 | 45,657 | SH | | SOLE | | 45,657 | 0 | 0 |
Ligand Pharmaceuticals, Inc. | Common | 53220K504 | 3,758 | 29,895 | SH | | SOLE | | 29,895 | 0 | 0 |
LivaNova PLC | Shares | G5509L101 | 1,109 | 11,400 | SH | | SOLE | | 11,400 | 0 | 0 |
LTC Properties, Inc. | Common | 502175102 | 6,660 | 145,421 | SH | | SOLE | | 145,421 | 0 | 0 |
Madrigal Pharmaceuticals, Inc. | Common | 558868105 | 1,671 | 13,340 | SH | | SOLE | | 13,340 | 0 | 0 |
Mallinckrodt public limited company | Sponsored ADR | G5785G107 | 717 | 32,980 | SH | | SOLE | | 32,980 | 0 | 0 |
Marinus Pharmaceuticals, Inc. | Common | 56854Q101 | 1,373 | 328,436 | SH | | SOLE | | 328,436 | 0 | 0 |
Masimo Corporation | Common | 574795100 | 1,482 | 10,715 | SH | | SOLE | | 10,715 | 0 | 0 |
McKesson Corporation | Common | 58155Q103 | 8,278 | 70,720 | SH | | SOLE | | 70,720 | 0 | 0 |
Medical Properties Trust, Inc. | Common | 58463J304 | 6,035 | 326,063 | SH | | SOLE | | 326,063 | 0 | 0 |
The Medicines Company | Common | 584688105 | 8,200 | 293,392 | SH | | SOLE | | 293,392 | 0 | 0 |
Medtronic plc | Shares | G5960L103 | 44,812 | 492,002 | SH | | SOLE | | 492,002 | 0 | 0 |
Merck & Co., Inc. | Common | 58933Y105 | 82,595 | 993,083 | SH | | SOLE | | 993,083 | 0 | 0 |
Merus N.V. | Common | N5749R100 | 4,692 | 317,671 | SH | | SOLE | | 317,671 | 0 | 0 |
Mirati Therapeutics, Inc. | Common | 60468T105 | 996 | 13,590 | SH | | SOLE | | 13,590 | 0 | 0 |
Molecular Templates, Inc. | Common | 608550109 | 837 | 144,110 | SH | | SOLE | | 144,110 | 0 | 0 |
Mylan N.V. | Shares | N59465109 | 26,729 | 943,152 | SH | | SOLE | | 943,152 | 0 | 0 |
MyoKardia, Inc. | Common | 62857M105 | 2,007 | 38,600 | SH | | SOLE | | 38,600 | 0 | 0 |
Myriad Genetics, Inc. | Common | 62855J104 | 682 | 20,549 | SH | | SOLE | | 20,549 | 0 | 0 |
Nektar Therapeutics | Common | 640268108 | 9,532 | 283,679 | SH | | SOLE | | 283,679 | 0 | 0 |
Neurocrine Biosciences, Inc. | Common | 64125C109 | 19,530 | 221,678 | SH | | SOLE | | 221,678 | 0 | 0 |
New Senior Investment Group Inc. | Common | 648691103 | 1,437 | 263,647 | SH | | SOLE | | 263,647 | 0 | 0 |
Novartis AG | Sponsored ADR | 66987V109 | 26,616 | 276,847 | SH | | SOLE | | 276,847 | 0 | 0 |
Novavax, Inc. | Common | 670002104 | 315 | 571,000 | SH | | SOLE | | 571,000 | 0 | 0 |
Novo Nordisk A/S | Sponsored ADR | 670100205 | 13,161 | 251,600 | SH | | SOLE | | 251,600 | 0 | 0 |
Novocure Limited | Ordinary Shares | G6674U108 | 3,177 | 65,964 | SH | | SOLE | | 65,964 | 0 | 0 |
NuVasive, Inc. | Common | 670704105 | 217 | 3,816 | SH | | SOLE | | 3,816 | 0 | 0 |
Omega Healthcare Investors, Inc. | Common | 681936100 | 12,981 | 340,266 | SH | | SOLE | | 340,266 | 0 | 0 |
Ovid Therapeutics Inc. | Sponsored ADR | 690469101 | 880 | 496,977 | SH | | SOLE | | 496,977 | 0 | 0 |
Perrigo Company plc | Shares | G97822103 | 1,046 | 21,718 | SH | | SOLE | | 21,718 | 0 | 0 |
Pfizer Inc. | Common | 717081103 | 87,945 | 2,070,765 | SH | | SOLE | | 2,070,765 | 0 | 0 |
Physicians Realty Trust | Common | 71943U104 | 5,717 | 303,908 | SH | | SOLE | | 303,908 | 0 | 0 |
Pieris Pharmaceuticals, Inc. | Common | 720795103 | 6,993 | 2,087,380 | SH | | SOLE | | 2,087,380 | 0 | 0 |
Portola Pharmaceuticals, Inc. | Sponsored ADR | 737010108 | 4,006 | 115,448 | SH | | SOLE | | 115,448 | 0 | 0 |
PRA Health Sciences, Inc. | Common | 69354M108 | 15,831 | 143,537 | SH | | SOLE | | 143,537 | 0 | 0 |
Protagonist Therapeutics, Inc. | Common | 74366E102 | 2,230 | 177,425 | SH | | SOLE | | 177,425 | 0 | 0 |
PTC Therapeutics, Inc. | Common | 69366J200 | 2,584 | 68,652 | SH | | SOLE | | 68,652 | 0 | 0 |
Puma Biotechnology, Inc. | Common | 74587V107 | 2,767 | 71,340 | SH | | SOLE | | 71,340 | 0 | 0 |
Quest Diagnostics, Inc. | Common | 74834L100 | 5,980 | 66,500 | SH | | SOLE | | 66,500 | 0 | 0 |
Quorum Health Corporation | Common | 74909E106 | 33 | 23,725 | SH | | SOLE | | 23,725 | 0 | 0 |
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 58,116 | 141,532 | SH | | SOLE | | 141,532 | 0 | 0 |
ResMed Inc. | Common | 761152107 | 7,171 | 68,974 | SH | | SOLE | | 68,974 | 0 | 0 |
Rhythm Pharmaceuticals, Inc. | Common | 76243J105 | 682 | 24,890 | SH | | SOLE | | 24,890 | 0 | 0 |
Sabra Health Care REIT, Inc. | Common | 78573L106 | 9,078 | 466,247 | SH | | SOLE | | 466,247 | 0 | 0 |
Sage Therapeutics, Inc. | Common | 78667J108 | 12,701 | 79,856 | SH | | SOLE | | 79,856 | 0 | 0 |
Sangamo Therapeutics, Inc. | Common | 800677106 | 2,304 | 241,538 | SH | | SOLE | | 241,538 | 0 | 0 |
Sanofi | Sponsored ADR | 80105N105 | 7,966 | 179,900 | SH | | SOLE | | 179,900 | 0 | 0 |
Sarepta Therapeutics, Inc. | Common | 803607100 | 17,622 | 147,847 | SH | | SOLE | | 147,847 | 0 | 0 |
Seattle Genetics, Inc. | Common | 812578102 | 21,234 | 289,925 | SH | | SOLE | | 289,925 | 0 | 0 |
Senior Housing Properties Trust | Common | 81721M109 | 4,214 | 357,720 | SH | | SOLE | | 357,720 | 0 | 0 |
Smith & Nephew plc | Shares | 83175M205 | 7,440 | 185,478 | SH | | SOLE | | 185,478 | 0 | 0 |
SPDR S&P Biotech ETF | S&P Biotech ETF | 78464A870 | 8,060 | 89,022 | SH | | SOLE | | 89,022 | 0 | 0 |
Spectrum Pharmaceuticals, Inc. | Common | 84763A108 | 1,226 | 114,670 | SH | | SOLE | | 114,670 | 0 | 0 |
STERIS plc | Shares | G8473T100 | 6,146 | 48,003 | SH | | SOLE | | 48,003 | 0 | 0 |
Stryker Corporation | Common | 863667101 | 24,305 | 123,050 | SH | | SOLE | | 123,050 | 0 | 0 |
Sutro Biopharma, Inc. | Common | 869367102 | 7,304 | 641,268 | SH | | SOLE | | 641,268 | 0 | 0 |
Syndax Pharmaceuticals, Inc. | Common | 87164F105 | 753 | 143,438 | SH | | SOLE | | 143,438 | 0 | 0 |
Syneos Health, Inc. | Class A | 87166B102 | 1,502 | 29,027 | SH | | SOLE | | 29,027 | 0 | 0 |
Takeda Pharmaceutical Company Limited | Sponsored ADS | 874060205 | 3,628 | 178,128 | SH | | SOLE | | 178,128 | 0 | 0 |
Teleflex Incorporated | Common | 879369106 | 1,927 | 6,379 | SH | | SOLE | | 6,379 | 0 | 0 |
Tenet Healthcare Corporation | Common | 88033G407 | 4,070 | 141,136 | SH | | SOLE | | 141,136 | 0 | 0 |
Tetraphase Pharmaceuticals, Inc. | Common | 88165N105 | 1,151 | 859,322 | SH | | SOLE | | 859,322 | 0 | 0 |
Teva Pharmaceutical Industries Limited | Sponsored ADR | 881624209 | 13,971 | 890,989 | SH | | SOLE | | 890,989 | 0 | 0 |
Thermo Fisher Scientific Inc. | Common | 883556102 | 39,072 | 142,743 | SH | | SOLE | | 142,743 | 0 | 0 |
Trillium Therapeutics Inc. | Common | 89620X506 | 294 | 446,099 | SH | | SOLE | | 446,099 | 0 | 0 |
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 5,338 | 76,958 | SH | | SOLE | | 76,958 | 0 | 0 |
uniQure N.V. | Shares | N90064101 | 1,178 | 19,751 | SH | | SOLE | | 19,751 | 0 | 0 |
United Therapeutics Corporation | Class B | 91307C102 | 4,843 | 41,261 | SH | | SOLE | | 41,261 | 0 | 0 |
Unitedhealth Group Incorporated | Common | 91324P102 | 80,145 | 324,133 | SH | | SOLE | | 324,133 | 0 | 0 |
Varian Medical Systems, Inc. | Common | 92220P105 | 3,717 | 26,227 | SH | | SOLE | | 26,227 | 0 | 0 |
Ventas, Inc. | Common | 92276F100 | 6,285 | 98,496 | SH | | SOLE | | 98,496 | 0 | 0 |
Verona Pharma plc | Sponsored ADR | 925050106 | 1,719 | 275,000 | SH | | SOLE | | 275,000 | 0 | 0 |
Vertex Pharmaceuticals Incorporated | Common | 92532F100 | 81,621 | 443,712 | SH | | SOLE | | 443,712 | 0 | 0 |
Viking Therapeutics, Inc. | Common | 92686J106 | 1,133 | 114,016 | SH | | SOLE | | 114,016 | 0 | 0 |
WaVe Life Sciences Ltd. | Shares | Y95308105 | 1,179 | 30,336 | SH | | SOLE | | 30,336 | 0 | 0 |
WellCare Health Plans, Inc. | Common | 94946T106 | 5,202 | 19,286 | SH | | SOLE | | 19,286 | 0 | 0 |
Welltower Inc. | Common | 95040Q104 | 18,416 | 237,322 | SH | | SOLE | | 237,322 | 0 | 0 |
Wright Medical Group N.V. | Ordinary Shares | N96617118 | 3,610 | 114,776 | SH | | SOLE | | 114,776 | 0 | 0 |
Xencor, Inc. | Common | 98401F105 | 2,248 | 72,382 | SH | | SOLE | | 72,382 | 0 | 0 |
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 10,172 | 79,654 | SH | | SOLE | | 79,654 | 0 | 0 |
Zoetis Inc. | Class A | 98978V103 | 25,872 | 257,001 | SH | | SOLE | | 257,001 | 0 | 0 |
Zogenix, Inc. | Common | 98978L204 | 4,938 | 89,762 | SH | | SOLE | | 89,762 | 0 | 0 |